Skip to main content
Log in

Slipped capital femoral epiphysis during the treatment of precocious puberty with a gonadotropin-releasing hormone-agonist: aetiological considerations

  • Short Report
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Douglas KK (1996) Slipped capital femoral epiphysis. In: Morrissy RT, Weinstein SL (eds) Lovell and Winter’s Pediatrics, 4th edn. Lippincott-Raven, Philadelphia, pp 993–1005

  2. Heatley FW, Greenwood RH, Boase DL (1976) Slipping of the upper femoral epiphysis in patients with intracranial tumors causing hypopituitarism and chiasmal compression. J Bone Joint Surg 58: 169–175

    CAS  Google Scholar 

  3. Hoffman HJ, EB Hendrick, Humphreys RP, Armstrong EA (1982) Investigation and management of suprasellar arachnoid cysts. J Neurosurg 57: 597–602

    CAS  PubMed  Google Scholar 

  4. Kempers MJE, Noordam C, Rouwe CW, Otten BJ (2001) Can GnRH-agonist treatment cause slipped capital femoral epiphysis? J Pediatr Endcrinol Metab 14: 729–734

    CAS  Google Scholar 

  5. Loder RT, Wittenberg B, DeSilva G (1995) Slipped capital femoral epiphysis associated with endocrine disorders. J Pediatr Orthop 15: 349–356

    CAS  PubMed  Google Scholar 

  6. Wilcox PG, Weiner DS, Leighley B (1988) Maturation factors in slipped capital femoral epiphysis. J Pediatr Orthop 8: 196–200

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Mami Mizutani Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fumiko Yamato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamato, F., Takaya, J., Higashino, H. et al. Slipped capital femoral epiphysis during the treatment of precocious puberty with a gonadotropin-releasing hormone-agonist: aetiological considerations. Eur J Pediatr 164, 173–174 (2005). https://doi.org/10.1007/s00431-004-1578-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-004-1578-7

Keywords

Navigation